GlassScriptPhysician profile
Ravneet Kaur
NPI 1821633082
$1,492.25
in general payments reported to CMS, 2019-2025
18 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $379 · 2023: $202 · 2024: $58.81 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $443.83 | 2021-2023 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $266.98 | 2021-2025 | |
| Amgen INC. | $163.46 | 2021-2025 | Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $114.10 | 2022 | |
| Novo Nordisk INC | $90.96 | 2021-2024 | Rybelsus |
| Lilly USA, LLC | $88.87 | 2021-2025 | Zepbound, Mounjaro |
| Madrigal Pharmaceuticals | $67.06 | 2025 | Rezdiffra |
| Merck Sharp & Dohme LLC | $40.64 | 2021 | |
| Mayne Pharma Commercial LLC | $34.22 | 2025 | |
| Exact Sciences Corporation | $31.58 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $24.76 | 2022 | |
| Axsome Therapeutics, INC. | $20.59 | 2025 | Auvelity |
| Daiichi Sankyo INC. | $18.58 | 2021 | |
| Genzyme Corporation | $18.39 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.15 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $17.82 | 2021 | |
| Amarin Pharma, INC. | $17.68 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $14.58 | 2023 | Prehevbrio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravneet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.